Investigation of the Effects of Artemisinin on Acetaminophen-Induced Acute Liver Toxicity
Chemical Research in Toxicology · 20.07.2026 · 39 (7) · 1389-1399
DOI: 10.1021/acs.chemrestox.6c00158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Research in Toxicology, online erschienen am 10.06.2026. Verfasst von Pelin Kurt und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Pharmacology, Faculty of Medicine, Atatürk University, Erzurum 25240, Türkiye. Hauptthemen laut MEDLINE: Artemisinins, Chemical and Drug Induced Liver Injury. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: T?rkiye Bilimsel ve Teknolojik Arastirma Kurumu.
Abstract (Originalsprache)
High Resolution Image Download MS PowerPoint Slide Paracetamol (PARA) is a widely used antipyretic and analgesic drug; however, overdose is a major cause of hepatotoxicity. Although N -acetylcysteine (NAC) is the standard antidote, its limitations necessitate the investigation of alternative therapeutic approaches. Artemisinin (ART), a natural compound with antioxidant and anti-inflammatory properties, was evaluated for its hepatoprotective potential in a paracetamol-induced acute liver injury model. Biochemical liver function parameters (ALT, AST), oxidative stress markers (SOD, GSH, MDA), molecular markers (TNF-α, IL-1β, iNOS, NF-κB, CYP2E1 mRNA expression), and histopathological changes were assessed using spectrophotometric assays, quantitative real-time PCR (qPCR), and histological staining methods. PARA administration significantly increased ALT and AST levels compared to the CONTROL group ( p < 0.001). Among the treatment groups, PARA + ART 14 significantly reduced these enzyme levels compared to the PARA group ( p < 0.001). ART treatment also increased antioxidant parameters (SOD, GSH) and decreased MDA levels compared to the PARA group ( p < 0.001), with effects comparable to PARA + NAC. Inflammation- and oxidative stress-related gene expressions were significantly elevated in the PARA group versus CONTROL ( p < 0.001), whereas PARA + ART 14 significantly downregulated all markers ( p < 0.001). Histopathological findings supported the biochemical and molecular results, showing partial improvement in PARA + ART 7 and more pronounced recovery in PARA + ART 14, while no significant improvement was observed in PARA + ART 35. These findings suggest that ART may exert dose-dependent hepatoprotective effects against paracetamol-induced liver injury by modulating oxidative stress and inflammatory responses. Further studies are needed to determine the optimal therapeutic dose and confirm its clinical potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Pharmacology, Faculty of Medicine, Atatürk University, Erzurum 25240, Türkiye.
- Department of Pharmacology, Faculty of Pharmacy, Atatürk University, Erzurum 25240, Türkiye.
- Department of Veterinary Histology and Embryology, Faculty of Veterinary Medicine, Atatürk University, Erzurum 25240, Türkiye.
ORCID-Profile: Rustem Anil Ugan
Förderung
- T?rkiye Bilimsel ve Teknolojik Arastirma Kurumu
Zitieren
APA
Kurt, P., Ugan, R. A., Aydin, A., Aydemir Celep, N., & Cadirci, E. (2026). Investigation of the Effects of Artemisinin on Acetaminophen-Induced Acute Liver Toxicity. Chemical Research in Toxicology, 39(7), 1389-1399. https://doi.org/10.1021/acs.chemrestox.6c00158
Vancouver
Kurt P, Ugan RA, Aydin A, Aydemir Celep N, Cadirci E. Investigation of the Effects of Artemisinin on Acetaminophen-Induced Acute Liver Toxicity. Chemical Research in Toxicology. 2026;39(7):1389-1399. doi:10.1021/acs.chemrestox.6c00158
BibTeX
@article{Kurt2026,
author = {Kurt, Pelin and Ugan, Rustem Anil and Aydin, Aylin and Aydemir Celep, Nevra and Cadirci, Elif},
title = {Investigation of the Effects of Artemisinin on Acetaminophen-Induced Acute Liver Toxicity},
journal = {Chemical Research in Toxicology},
year = {2026},
volume = {39},
number = {7},
pages = {1389--1399},
doi = {10.1021/acs.chemrestox.6c00158}
}
EUVIMED